Overall, this study concluded that miR-373-dependent SIRT1 inhibition displays anti-proliferative and pro-apoptotic roles in PC cells via PGC-1α/NRF2 pathway, which highlights miR-373 as a potential target for PC treatment. Here, PPARGC1A is linked to pachyonychia congenita.